Puma Biotech (PBYI) delivered earnings and revenue surprises of 207.14% and 14.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
9h
Hosted on MSNPuma's New Sneaker Collab Looks Like It's Floating in Mid-AirNot quite, but Puma's first collaboration with Parisian vegan footwear brand Rombaut features a perpetually lifted heel which ...
George Clelland, Investment Product Manager at Puma Investments, explores how VCTs can be a powerful tax planning tool for ...
Pete Alonso is the present, but his status on the team beyond this year remains uncertain. Access the Mets beat like never ...
Puma and Brooks settle dispute over running shoe patents. Discover the implications for the footwear industry.
The PUMA drops keep coming, the most recent arriving as the ‘Forever’ pack. PUMA pulls inspiration from the brands legacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results